-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Alliance centralized procurement has become a trend.
At present, there are 26 inter-provincial alliances for centralized drug procurement in the country
.
The third batch of "eight provinces and two districts" included 18 varieties, including 16 injections, and finally 17 varieties were to be selected, with a maximum drop of 98% and an average drop of 54.
76%
.
Looking at the centralized procurement of various alliances, it can be seen that injections have become the focus of centralized procurement
.
Recently, the results of the third batch of drug centralized procurement of the "eight provinces and two districts" inter-provincial alliance led by Inner Mongolia have been released, involving 18 procurement varieties, involving cardiovascular and cerebrovascular diseases, respiratory diseases, and antibiotics with large clinical doses.
Medicines for common and chronic diseases
.
Alliance members include: Inner Mongolia, Shanxi, Liaoning, Jilin, Heilongjiang, Hainan, Sichuan, Guizhou, Tibet, Qinghai 10 provinces (regions)
.
In the end, 23 product specifications of 17 varieties of 25 companies were selected, and the standard of dihyprophylline injection was passed, with an average decrease of 54.
76%
.
According to the "People's Daily" report, among them, the piracetam injection of Dandong Yichuang Pharmaceutical Co.
, Ltd.
has the highest decline, with a decline of 98.
02%, and each injection has dropped from 49.
6 yuan to 0.
98 yuan
.
Previously (June 2, 2021), the "Announcement of "Eight Provinces and Two Districts" Inter-Provincial Alliance Drug Concentration and Volume Procurement" was released and confirmed that 21 product specifications were included in centralized procurement, of which 18 were injections.
This is the second batch of the alliance.
Collection of medicines
.
In the end, 14 pharmaceutical companies were selected, but the prices were not disclosed
.
Mezlocillin Sodium Injection, Clindamycin Phosphate Injection, Fluorouracil Injection, Lidocaine Injection, Calcitriol Oral Normal-Release Formulations 5 Drug Flow Standards
.
Among them, Shandong Luoxin Pharmaceutical is the biggest winner, with three drugs to be selected, including tropisetron hydrochloride for injection, cefotiam hydrochloride for injection, and cefathiamidine for injection
.
In addition, Hunan Sailong Pharmaceutical also has two varieties to be selected, including tranexamic acid injection and argatroban injection
.
The winning price was not announced at that time, but in the notice on the implementation of the results of the “eight provinces and two districts” inter-provincial alliance drug centralized procurement issued by Hainan Province, the winning prices of some varieties were announced
.
For details, please refer to the following table: The current inter-provincial alliance has become a trend.
Currently, there are 26 inter-provincial alliances in the country, including: Sanming Alliance, Shaanxi leading 11 provincial alliances, and Shaanxi leading anticancer drug 14 provinces (regions) The alliance, Chongqing leads the alliance of 5 provinces, Sichuan leads the alliance of six provinces and two districts, "Shanghai, Jiangsu, Zhejiang, Anhui, and Fujian" alliance of four provinces and one city, Guangdong leads the alliance of 10 provinces (cephalexin), Guangdong leads the alliance of 13 provinces, and Guangdong leads the alliance of 16 provinces and autonomous regions.
Alliance, Beijing-Tianjin-Hebei "3+N" Alliance, Xinjiang "2+N" Alliance, Heilongjiang Leading Eight Provinces and Two Regions Alliance, Chongqing 8 Provinces and Regions Common Drug Alliance, Chongqing 9 Provinces and Regions Shortage Drug Alliance, Gansu-Shaanxi Alliance, Lu-Jin Alliance, as well as the Centralized Procurement Alliance of Chinese Patent Medicines in 19 Hubei Provinces.
.
.
At present, there are 26 inter-provincial alliances for centralized drug procurement in the country
.
The third batch of "eight provinces and two districts" included 18 varieties, including 16 injections, and finally 17 varieties were to be selected, with a maximum drop of 98% and an average drop of 54.
76%
.
Looking at the centralized procurement of various alliances, it can be seen that injections have become the focus of centralized procurement
.
Recently, the results of the third batch of drug centralized procurement of the "eight provinces and two districts" inter-provincial alliance led by Inner Mongolia have been released, involving 18 procurement varieties, involving cardiovascular and cerebrovascular diseases, respiratory diseases, and antibiotics with large clinical doses.
Medicines for common and chronic diseases
.
Alliance members include: Inner Mongolia, Shanxi, Liaoning, Jilin, Heilongjiang, Hainan, Sichuan, Guizhou, Tibet, Qinghai 10 provinces (regions)
.
In the end, 23 product specifications of 17 varieties of 25 companies were selected, and the standard of dihyprophylline injection was passed, with an average decrease of 54.
76%
.
According to the "People's Daily" report, among them, the piracetam injection of Dandong Yichuang Pharmaceutical Co.
, Ltd.
has the highest decline, with a decline of 98.
02%, and each injection has dropped from 49.
6 yuan to 0.
98 yuan
.
Previously (June 2, 2021), the "Announcement of "Eight Provinces and Two Districts" Inter-Provincial Alliance Drug Concentration and Volume Procurement" was released and confirmed that 21 product specifications were included in centralized procurement, of which 18 were injections.
This is the second batch of the alliance.
Collection of medicines
.
In the end, 14 pharmaceutical companies were selected, but the prices were not disclosed
.
Mezlocillin Sodium Injection, Clindamycin Phosphate Injection, Fluorouracil Injection, Lidocaine Injection, Calcitriol Oral Normal-Release Formulations 5 Drug Flow Standards
.
Among them, Shandong Luoxin Pharmaceutical is the biggest winner, with three drugs to be selected, including tropisetron hydrochloride for injection, cefotiam hydrochloride for injection, and cefathiamidine for injection
.
In addition, Hunan Sailong Pharmaceutical also has two varieties to be selected, including tranexamic acid injection and argatroban injection
.
The winning price was not announced at that time, but in the notice on the implementation of the results of the “eight provinces and two districts” inter-provincial alliance drug centralized procurement issued by Hainan Province, the winning prices of some varieties were announced
.
For details, please refer to the following table: The current inter-provincial alliance has become a trend.
Currently, there are 26 inter-provincial alliances in the country, including: Sanming Alliance, Shaanxi leading 11 provincial alliances, and Shaanxi leading anticancer drug 14 provinces (regions) The alliance, Chongqing leads the alliance of 5 provinces, Sichuan leads the alliance of six provinces and two districts, "Shanghai, Jiangsu, Zhejiang, Anhui, and Fujian" alliance of four provinces and one city, Guangdong leads the alliance of 10 provinces (cephalexin), Guangdong leads the alliance of 13 provinces, and Guangdong leads the alliance of 16 provinces and autonomous regions.
Alliance, Beijing-Tianjin-Hebei "3+N" Alliance, Xinjiang "2+N" Alliance, Heilongjiang Leading Eight Provinces and Two Regions Alliance, Chongqing 8 Provinces and Regions Common Drug Alliance, Chongqing 9 Provinces and Regions Shortage Drug Alliance, Gansu-Shaanxi Alliance, Lu-Jin Alliance, as well as the Centralized Procurement Alliance of Chinese Patent Medicines in 19 Hubei Provinces.
.
.
